These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38636168)

  • 41. Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone.
    Perrien DS; Achenbach SJ; Bledsoe SE; Walser B; Suva LJ; Khosla S; Gaddy D
    J Clin Endocrinol Metab; 2006 May; 91(5):1848-54. PubMed ID: 16449331
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibin B as a screening tool for early detection and treatment monitoring of central precocious puberty.
    Jeong HR; Lee HJ; Shim YS; Kang MJ; Yang S; Hwang IT
    Gynecol Endocrinol; 2020 Sep; 36(9):768-771. PubMed ID: 32162574
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition.
    Sowers MR; Eyvazzadeh AD; McConnell D; Yosef M; Jannausch ML; Zhang D; Harlow S; Randolph JF
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3478-83. PubMed ID: 18593767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effects of moxibustion at Shenshu (BL 23) on level of sex hormones and AMH in sub-health peri-menopausal women].
    Shen J; Shen M; Li Z; Zhang R; Li X; Ai B
    Zhongguo Zhen Jiu; 2017 Apr; 37(4):381-385. PubMed ID: 29231589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].
    Mohamed Y; Haifa H; Datel O; Fadoua HN; Smeh BH; Mahbouba J; Saoussen Z; Bejia I; Mongi T; Mohamed FN; Naceur B
    Tunis Med; 2014 May; 92(5):304-10. PubMed ID: 25504382
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle].
    Chen Y; Yu Q; Zhang YW; He FF; Sun ZY
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16831355
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlations between anti-müllerian hormone, inhibin B, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes.
    Cupisti S; Dittrich R; Mueller A; Strick R; Stiegler E; Binder H; Beckmann MW; Strissel P
    Eur J Med Res; 2007 Dec; 12(12):604-8. PubMed ID: 18024272
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum and intratesticular inhibin B, AMH, and spermatogonial numbers in trans women at gender-confirming surgery: An observational study.
    Schneider F; Dabel J; Sandhowe-Klaverkamp R; Neuhaus N; Schlatt S; Kliesch S; Wistuba J
    Andrology; 2021 Nov; 9(6):1781-1789. PubMed ID: 34085780
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Relevance of Osteoclastic and Osteoblastic Activity Markers Follow-Up in Patients on Antiresorptive Osteoporosis Treatment.
    Smilic TN; Novakovic TR; Markovic-Jovanovic SR; Smilic LLJ; Mitic JS; Radunovic ML
    J Clin Densitom; 2018; 21(3):322-328. PubMed ID: 29103946
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized trial comparing efficacies of zoledronate and alendronate for improving bone mineral density and inhibiting bone remodelling in women with post-menopausal osteoporosis.
    Tan W; Sun J; Zhou L; Li Y; Wu X
    J Clin Pharm Ther; 2016 Oct; 41(5):519-23. PubMed ID: 27440710
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Seminal plasma concentrations of Anti-Müllerian hormone and inhibin B predict motile sperm recovery from cryopreserved semen in asthenozoospermic men: a prospective cohort study.
    Nery SF; Vieira MA; Dela Cruz C; Lobach VN; Del Puerto HL; Torres PB; Rocha AL; Reis AB; Reis FM
    Andrology; 2014 Nov; 2(6):918-23. PubMed ID: 25269872
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of electroacupuncture at different acupoints on follicle development and related factors in serum and ovary tissues of PCOS rats].
    Xu G; Zhang AD; Wang X; Liu JD; Feng JW; Chen YL
    Zhen Ci Yan Jiu; 2019 Oct; 44(10):740-6. PubMed ID: 31657164
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Maternal menopause as a predictor of anti-Mullerian hormone level and antral follicle count in daughters during reproductive age.
    Bentzen JG; Forman JL; Larsen EC; Pinborg A; Johannsen TH; Schmidt L; Friis-Hansen L; Nyboe Andersen A
    Hum Reprod; 2013 Jan; 28(1):247-55. PubMed ID: 23136135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
    Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
    Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination therapy of curcumin and alendronate modulates bone turnover markers and enhances bone mineral density in postmenopausal women with osteoporosis.
    Khanizadeh F; Rahmani A; Asadollahi K; Ahmadi MRH
    Arch Endocrinol Metab; 2018 Aug; 62(4):438-445. PubMed ID: 30304108
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hot flushes and reproductive hormone levels during the menopausal transition.
    Dhanoya T; Sievert LL; Muttukrishna S; Begum K; Sharmeen T; Kasim A; Chowdhury O; Bentley GR
    Maturitas; 2016 Jul; 89():43-51. PubMed ID: 27180159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Significance of inhibin B and anti-Müllerian hormone in seminal plasma: a preliminary study.
    Duvilla E; Lejeune H; Trombert-Paviot B; Gentil-Perret A; Tostain J; Levy R
    Fertil Steril; 2008 Feb; 89(2):444-8. PubMed ID: 17681330
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum osteopontin levels in relation to bone mineral density and bone turnover markers in postmenopausal women.
    Wei QS; Huang L; Tan X; Chen ZQ; Chen SM; Deng WM
    Scand J Clin Lab Invest; 2016; 76(1):33-9. PubMed ID: 26414945
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Relationship Between GNRI Changes and Bone Metabolism Parameters and the Occurrence of Osteoporosis in Elderly Male Patients with T2D.
    Liang F; Sun L; Wang Y
    Altern Ther Health Med; 2023 Jan; 29(1):85-89. PubMed ID: 36480682
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biochemical markers as predictors of rates of bone loss after menopause.
    Rogers A; Hannon RA; Eastell R
    J Bone Miner Res; 2000 Jul; 15(7):1398-404. PubMed ID: 10893690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.